Hjem › Mantelcellelymfom › North Carolina › Durham
Kliniske studier for Mantelcellelymfom i Durham, NC
13 studier for Mantelcellelymfom søker deltakere på steder i og rundt Durham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
RekruttererFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
RekruttererFase 3
- Duke University, Durham
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruttererFase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi unna
DALY II USA/ MB-CART2019.1 for DLBCL
RekruttererFase 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekruttererFase 1
- Duke University Medical Center, Durham
Registry of Older Patients With Cancer
RekruttererObservasjonsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi unna
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
RekruttererFase 1
- Duke Univerisity, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
RekruttererFase 1
- Duke University, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
RekruttererFase 1
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi unna
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
RekruttererFase 1
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi unna
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RekruttererObservasjonsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi unna
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekruttererFase 1
- University of North Carolina, Chapel Hill · 10 mi unna
Mantelcellelymfom-studier i andre byer
- Houston, TX15 studier
- Baldwin Park, CA15 studier
- New York City, NY12 studier
- Seattle, WA12 studier
- Milwaukee, WI12 studier
- Boston, MA11 studier
- Nashville, TN11 studier
- Columbus, OH11 studier
- Chicago, IL10 studier
- Rochester, MN9 studier
- Portland, OR9 studier
- Atlanta, GA8 studier
Andre studier i Durham
- Brystkreft64 studier
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft39 studier
- Multipelt myelom37 studier
- Akut myelogen leukemi33 studier
- Metastatisk kreft33 studier
- Prostatakreft32 studier
- Lungekreft32 studier
- Kolorektal kreft28 studier
- Eggstokkreft27 studier
- Kronisk lymfatisk leukemi27 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.